SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Veeco Instruments Inc – ‘FWP’ on 1/12/17 re: Veeco Instruments Inc

On:  Thursday, 1/12/17, at 6:00am ET   ·   Accession #:  1104659-17-2022   ·   File #:  333-215499

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/12/17  Veeco Instruments Inc             FWP                    1:106K Veeco Instruments Inc             Merrill Corp-MD/FA

Free-Writing Prospectus   —   Rule 163/433
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: FWP         Free-Writing Prospectus                             HTML     69K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Issuer Free Writing Prospectus

Filed Pursuant to Rule 433

Registration Statement No. 333- 215499

Supplementing the Preliminary Prospectus Supplement dated January 10, 2017 (To Prospectus dated January 10, 2017)

 

PRICING TERM SHEET

 

The information in this pricing term sheet supplements the Preliminary Prospectus Supplement, dated January 10, 2017 (the “Preliminary Prospectus”), related to Veeco Instruments Inc.’s offering of its 2.70% Convertible Senior Notes due 2023 (the “Notes”), and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. In all other respects, this term sheet is qualified in its entirety by reference to the Preliminary Prospectus. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus. Veeco Instruments Inc. has increased the size of the offering to $300,000,000 (or $345,000,000 if the underwriters’ over-allotment option is exercised in full). The final prospectus supplement relating to the offering will reflect conforming changes relating to such increase in the size of the offering.

 

Issuer:

 

Veeco Instruments Inc. 

 

 

 

Ticker / Exchange for Common Stock:

 

“VECO” / NASDAQ Global Select Market

 

 

 

Pricing Date:

 

January 11, 2017 

 

 

 

Trade Date:

 

January 12, 2017 

 

 

 

Closing Date:

 

January 18, 2017

 

 

 

Aggregate Principal Amount of Notes Offered:

 

$300,000,000 (or $345,000,000 if the underwriters’ over-allotment option is exercised in full).

 

 

 

Issue Price:

 

100%

 

 

 

Maturity:

 

January 15, 2023, unless earlier repurchased, redeemed or converted

 

 

 

Interest Rate:

 

2.70% per annum from January 18, 2017

 

 

 

Interest Payment Dates:

 

January 15 and July 15, beginning July 15, 2017

 

 

 

Ranking:

 

Senior unsecured obligations ranking:

 

·             senior in right of payment to any of the Issuer’s indebtedness that is expressly subordinated in right of payment to the Notes;

 

·             equal in right of payment to any of the Issuer’s unsecured indebtedness that is not so subordinated (including the Issuer’s unsecured trade payables);

 

·             effectively junior in right of payment to any of the Issuer’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and

 

·             structurally junior to all indebtedness and other liabilities (including trade payables) of the Issuer’s subsidiaries.

 

 

 

Last Reported Sale Price on January 11, 2017:

 

$27.80 per share of the Issuer’s common stock

 

 

 

Conversion Premium:

 

Approximately 44.0% above the Last Reported Sale Price on January 11, 2017

 



 

 

 

 

 

 

 

 

 

Initial Conversion Rate:

 

24.9800 shares of the Issuer’s common stock per $1,000 principal amount of Notes

 

 

 

Initial Conversion Price:

 

Approximately $40.03 per share of the Issuer’s common stock

 

 

 

Redemption:

 

The Issuer may not redeem the Notes prior to January 20, 2021. The Issuer may redeem for cash all or any portion of the Notes, at the Issuer’s option, on or after January 20, 2021 if the last reported sale price of the Issuer’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Issuer provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Issuer provide notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No “sinking fund” is provided for the Notes.

 

 

 

Use of Proceeds:

 

The Issuer estimates that the proceeds from this offering will be approximately $291.5 million (or $335.4 million if the underwriters exercise their over-allotment option in full), after deducting fees and estimated expenses payable by the Issuer.


The Issuer intends to use the net proceeds from this offering to fund potential acquisitions, to repurchase shares and for other general corporate purposes.

 

 

 

Price to the Public, Underwriting Discounts and Proceeds:

 

The following table shows the price to the public, underwriting discounts and commissions and proceeds to the Issuer (before expenses):

 

 

 

 

 

Per Note

 

Total

 

 

 

Price to the public(1)

 

100

%

$

300,000,000

 

 

 

Underwriting discounts and commissions

 

2.5

%

$

7,500,000

 

 

 

Proceeds to Veeco Instruments Inc. (before expenses)

 

97.5

%

$

292,500,000

 

 

 

 


 

 

(1)           Plus accrued interest, if any, from January 18, 2017.

 

 

 

Joint Book-Running Managers:

 

Barclays, Wells Fargo Securities

 

 

 

CUSIP Number:

 

922417AD2

 

 

 

ISIN:

 

US922417AD23

 

 

 

Adjustment to Conversion Rate Upon a Make-Whole Fundamental Change or a Notice of Redemption:

 

If the effective date of a make-whole fundamental change occurs prior to the maturity date of the Notes or the Issuer give a notice of redemption with respect to any or all of the Notes and, in each case, a holder elects to convert its Notes in connection with such make-whole fundamental change or redemption notice, the following table sets forth the number of additional shares of the Issuer’s common stock by which the conversion rate will be increased per $1,000 principal amount of

 

2



 

 

 

Notes for each stock price and effective date set forth below:

 

Stock Price

 

Effective Date

 

$27.80

 

$30.00

 

$40.03

 

$52.04

 

$60.00

 

$80.00

 

$105.00

 

$130.00

 

$155.00

 

$180.00

 

$205.00

 

$230.00

 

January 18, 2017

 

10.9912

 

9.5897

 

5.5421

 

3.2343

 

2.3709

 

1.2013

 

0.5715

 

0.2804

 

0.1311

 

0.0516

 

0.0106

 

0.0000

 

January 15, 2018

 

10.9912

 

9.3492

 

5.2278

 

2.9456

 

2.1160

 

1.0278

 

0.4682

 

0.2193

 

0.0955

 

0.0318

 

0.0016

 

0.0000

 

January 15, 2019

 

10.9912

 

9.1378

 

4.8842

 

2.6183

 

1.8274

 

0.8372

 

0.3605

 

0.1591

 

0.0627

 

0.0152

 

0.0000

 

0.0000

 

January 15, 2020

 

10.9912

 

8.9026

 

4.4525

 

2.2087

 

1.4731

 

0.6179

 

0.2469

 

0.1007

 

0.0335

 

0.0025

 

0.0000

 

0.0000

 

January 15, 2021

 

10.9912

 

8.6028

 

3.8503

 

1.6562

 

1.0142

 

0.3655

 

0.1336

 

0.0500

 

0.0115

 

0.0000

 

0.0000

 

0.0000

 

January 15, 2022

 

10.9912

 

8.3533

 

2.8921

 

0.8470

 

0.4026

 

0.1020

 

0.0385

 

0.0135

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

January 15, 2023

 

10.9912

 

8.3533

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

0.0000

 

 

The exact stock price and effective date may not be set forth in the table above, in which case:

 

·                  If the stock price is between two stock prices in the table or the effective date is between two effective dates in the table, the number of additional shares of the Issuer’s common stock by which the conversion rate will be increased will be determined by a straight-line interpolation between the number of additional shares set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365-day year.

 

·                  If the stock price is greater than $230.00 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of the table above), no additional shares of the Issuer’s common stock will be added to the conversion rate.

 

·                  If the stock price is less than $27.80 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of the table above), no additional shares of the Issuer’s common stock will be added to the conversion rate.

 

Notwithstanding the foregoing, in no event will the conversion rate per $1,000 principal amount of Notes exceed 35.9712 shares of the Issuer’s common stock, subject to adjustment in the same manner as the conversion rate as set forth under “Description of the Notes—Conversion Rights—Conversion Rate Adjustments” in the Preliminary Prospectus.

 


 

This communication is intended for the sole use of the person to whom it is provided by the sender.

 

The Issuer has filed a registration statement (including a prospectus, dated January 10, 2017 and a preliminary prospectus supplement, dated January 10, 2017) with the Securities and Exchange Commission, or SEC, for the offering of the Notes. Before you invest, you should read the Preliminary Prospectus Supplement, the accompanying Prospectus and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and the offering of the Notes. You may get these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, a copy of the Preliminary Prospectus can be obtained by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 1-888-603-5847 or by email at barclaysprospectus@broadridge.com, or from Wells Fargo Securities, LLC, 375 Park Avenue, New York, NY 10152, Attention: Equity Syndicate Department, or by telephone at 1-800-326-5897, or by email at cmclientsupport@wellsfargo.com.

 

3



 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of these securities, in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.

 

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

 

4



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘FWP’ Filing    Date    Other Filings
1/15/23
1/15/22
1/20/21
1/15/21
1/15/20
1/15/19
1/15/18
7/15/17
1/18/17
Filed on:1/12/17
1/11/17
1/10/17424B5,  8-K,  S-3ASR
 List all Filings 
Top
Filing Submission 0001104659-17-002022   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 6:07:43.1am ET